Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Ipragliflozin/sitagliptin - Astellas Pharma/MSD KK

Next Previous
Search
Drug Profile

Ipragliflozin/sitagliptin - Astellas Pharma/MSD KK

Alternative Names: Ipragliflozin L-proline/sitagliptin; MK 0431J; Sitagliptin phosphate hydrate/ipragliflozin L-Proline; Sitagliptin/ipragliflozin; Sitagliptin/ipragliflozin L-proline; SUJANU

Latest Information Update: 30 Oct 2021

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Astellas Pharma; MSD KK
  • Developer Astellas Pharma; Kotobuki Pharmaceutical; MSD KK
  • Class Antihyperglycaemics; Glucosides; Pyrazines; Small molecules; Thiophenes; Triazoles
  • Mechanism of Action Dipeptidyl peptidase 4 inhibitors; Sodium-glucose transporter 2 inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Type 2 diabetes mellitus

Most Recent Events

  • 22 May 2018 Launched for Type-2 diabetes mellitus in Japan (PO) - First Global Launch
  • 23 Mar 2018 Registered for Type-2 diabetes mellitus in Japan (PO)
  • 26 May 2017 Chemical structure information added

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top